Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Esperion Therapeutics, Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Fasting LDL-cholesterol greater than or equal to 100 mg/dL at screening
Men and nonpregnant, nonlactating women
Use of stable lipid-modifying therapy for at least 4 weeks prior to screening that includes ezetimibe 10mg daily
You may not be if
Fasting blood triglycerides greater than or equal to 500 mg/dL
Body Mass Index (BMI) greater than or equal to 50 kg/m2
Recent history of clinically significant cardiovascular disease
Use of statin therapy where doses are greater than those defined as "low-dose" within 4 weeks prior to screening; where "low-dose" is defined as an average daily dose of rosuvastatin 5 mg, atorvastatin 10 mg, simvastatin 10 mg, lovastatin 20 mg, pravastatin 40 mg, fluvastatin 40 mg, or pitavastatin 2 mg.